Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  178 results for ""Parkinson disease""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease.

  • Authors : Dai L; Department of Neurology, Renmin Hospital of Wuhan University, Wuhan, China.; Wang J

Subjects: alpha-Synuclein*/alpha-Synuclein*/alpha-Synuclein*/metabolism ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/pathology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism

  • Source: PLoS biology [PLoS Biol] 2025 Feb 18; Vol. 23 (2), pp. e3002974. Date of Electronic Publication: 2025 Feb 18 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease.

  • Authors : Bérard M; CHU de Québec Research Center, Axe Neurosciences, Quebec City, Canada.; Department of Molecular Medicine, Faculty of Medicine, Université Laval, Quebec City, Canada.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism ; alpha-Synuclein*/alpha-Synuclein*/alpha-Synuclein*/metabolism; Cluster Analysis

  • Source: PLoS biology [PLoS Biol] 2022 Mar 09; Vol. 20 (3), pp. e3001578. Date of Electronic Publication: 2022 Mar 09 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Are oligodendrocytes bystanders or drivers of Parkinson's disease pathology?

  • Authors : Salazar Campos JM; Metabolic Biochemistry, Biomedical Center (BMC), Faculty of Medicine, LMU Munich, Munich, Germany.; Burbulla LF

Subjects: Oligodendroglia*/Oligodendroglia*/Oligodendroglia*/metabolism ; Oligodendroglia*/Oligodendroglia*/Oligodendroglia*/pathology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/pathology

  • Source: PLoS biology [PLoS Biol] 2025 Jan 08; Vol. 23 (1), pp. e3002977. Date of Electronic Publication: 2025 Jan 08 (Print Publication: 2025).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Trojan horses and tunneling nanotubes enable α-synuclein pathology to spread in Parkinson disease.

  • Authors : Rajasekaran S; Department of Biochemistry & Molecular Biology, Louisiana State University Health Sciences Center, United States of America.; Witt SN

Subjects: Nanotubes* ; Parkinson Disease* ; Prions*

  • Source: PLoS biology [PLoS Biol] 2021 Jul 20; Vol. 19 (7), pp. e3001331. Date of Electronic Publication: 2021 Jul 20 (Print Publication: 2021).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

FBXO7/ntc and USP30 antagonistically set the ubiquitination threshold for basal mitophagy and provide a target for Pink1 phosphorylation in vivo.

  • Authors : Sanchez-Martinez A; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.; Martinez A

Subjects: Parkinson Disease, Secondary* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/metabolism; Animals

  • Source: PLoS biology [PLoS Biol] 2023 Aug 03; Vol. 21 (8), pp. e3002244. Date of Electronic Publication: 2023 Aug 03 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101183755 Publication Model: eCollection Cited Medium: Internet

Record details

×
  • 1-10 of  178 results for ""Parkinson disease""